نتایج جستجو برای: budesonide

تعداد نتایج: 2228  

Journal: :International Journal of Pharmaceutics 2021

The objective of this work was to evaluate the potential use a new polymer (PAMgA) in development sustained release matrix tablets for treatment bowel inflammatory diseases. For purpose, budesonide, highly lipophilic compound, used as model drug. Tablets with two reticulation grades PAMgA (PAMgA 5 and 40) 9 mg budesonide were developed characterized. All studies carried out using biorelevant me...

Journal: :Cancer prevention research 2011
Giulia Veronesi Eva Szabo Andrea Decensi Aliana Guerrieri-Gonzaga Massimo Bellomi Davide Radice Stefania Ferretti Giuseppe Pelosi Matteo Lazzeroni Davide Serrano Scott M Lippman Lorenzo Spaggiari Angela Nardi-Pantoli Sergio Harari Clara Varricchio Bernardo Bonanni

Screening CT identifies small peripheral lung nodules, some of which may be pre- or early invasive neoplasia. Secondary end point analysis of a previous chemoprevention trial in individuals with bronchial dysplasia showed reduction in size of peripheral nodules by inhaled budesonide. We performed a randomized, double-blind, placebo-controlled phase IIb trial of inhaled budesonide in current and...

2014
Nikolaos Lazarinis Leif Jørgensen Tommy Ekström Leif Bjermer Barbro Dahlén Teet Pullerits Gunilla Hedlin Kai-Håkon Carlsen Kjell Larsson

BACKGROUND In mild asthma exercise-induced bronchoconstriction (EIB) is usually treated with inhaled short-acting β2 agonists (SABAs) on demand. OBJECTIVE The hypothesis was that a combination of budesonide and formoterol on demand diminishes EIB equally to regular inhalation of budesonide and is more effective than terbutaline inhaled on demand. METHODS Sixty-six patients with asthma (>12 ...

Journal: :Archives of disease in childhood 1993
L Agertoft S Pedersen

Two hundred and forty one children with chronic perennial asthma, who had been treated with budesonide via a metered dose inhaler with a spacer device (Nebuhaler), had their normal dose of budesonide reduced by 50% to determine if they had been overtreated. Within three weeks, asthma control deteriorated in 126 patients to such an extent that budesonide had to be increased to the normal dose. A...

2017
David T. Rubin Russell D. Cohen William J. Sandborn Gary R. Lichtenstein Jeffrey Axler Robert H. Riddell Cindy Zhu Andrew C. Barrett Enoch Bortey William P. Forbes

Background and Aims Safety and efficacy of budesonide multimatrix, an oral extended-release second-generation corticosteroid designed for targeted delivery throughout the colon, were examined for induction of remission in patients with mild to moderate ulcerative colitis refractory to baseline mesalamine therapy. Methods A randomised, double-blind, placebo-controlled, multicentre trial evalua...

Journal: :Journal of controlled release : official journal of the Controlled Release Society 1999
K Nakamura Y Maitani A M Lowman K Takayama N A Peppas T Nagai

Microparticles of novel, bioadhesive graft copolymers of polymethacrylic acid and polyethylene glycol (P(MAA-g-EG)) were prepared. The aims of this study were to investigate the uptake and release kinetics of budesonide from P(MAA-g-EG) in vitro as well as the pharmacokinetics following nasal administration of the polymer contained budesonide. The loading of budesonide into the pH-sensitive pol...

2016
Andreas Münch Johan Bohr Stephan Miehlke Cecilia Benoni Martin Olesen Åke Öst Lars Strandberg Per M Hellström Erik Hertervig Peter Armerding Jiri Stehlik Greger Lindberg Jan Björk Annika Lapidus Robert Löfberg Ole Bonderup Sören Avnström Martin Rössle Karin Dilger Ralph Mueller Roland Greinwald Curt Tysk Magnus Ström

OBJECTIVE This 1-year study aimed to assess low-dose budesonide therapy for maintenance of clinical remission in patients with collagenous colitis. DESIGN A prospective, randomised, placebo-controlled study beginning with an 8-week open-label induction phase in which patients with histologically confirmed active collagenous colitis received budesonide (Budenofalk, 9 mg/day initially, tapered ...

Journal: :Alimentary pharmacology & therapeutics 2003
S Edsbäcker B Bengtsson P Larsson P Lundin A Nilsson J Ulmius P Wollmer

AIMS To investigate the gastrointestinal pharmacokinetics of controlled-release (Entocort) and standard budesonide capsules. METHODS Six Crohn's disease patients and eight healthy controls were given controlled-release capsules containing budesonide and an inert 111In label, following breakfast. In the patients, a standard capsule containing deuterium-labelled budesonide was given simultaneou...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 1997
A Tunek K Sjödin G Hallström

Microsomes from human lung and liver catalyze the formation of fatty acid esters of budesonide, a glucocorticoid used for inhalation treatment of asthma. The conjugation was dependent on coenzyme A and ATP. Addition of free fatty acids to the incubations affected the pattern of metabolites, but ester formation was observed also without such addition. Budesonide oleate, palmitate, linoleate, pal...

Journal: :Drugs & Therapy Perspectives 2021

Budesonide/formoterol (Symbicort®) as needed (PRN) is effective for the prevention of severe exacerbations in mild asthma. This economic model evaluated cost effectiveness budesonide/formoterol PRN versus (1) a short-acting β2-agonist (SABA) and (2) maintenance budesonide plus SABA asthma Malaysia. A decision analytical was developed to evaluate downstream consequences comparators from payer’s ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید